Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

ARIANA Grande shot to fame aged 16 as an innocent-looking Nickelodeon star with bright red hair. But since then, the child ...

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...

Weight loss, a possible treatment for opioid use disorder, and reduced risks for heart disease, stroke, and a slew of other diseases—those are just some of the benefits of Ozempic, the type 2 ...

Objective: To assess adult consumers' previous experience with measuring devices for oral liquids, compare the accuracy of an oral syringe with that of a dosing cup, and determine consumer ...